TherapeuticsMD (TXMD) Q1 2024 Annual Earnings
TXMD·Reported May 10, 2024·Before market open
TherapeuticsMD reported Q1 2024 revenue of $313.0K, missed analyst consensus of $500.0K by $187.0K. Diluted EPS came in at $-0.07, missed the $0.03 consensus by $0.10.
Revenue
$313.0Kmissed by $187.0K
Consensus: $500.0KDiluted EPS
$-0.07missed by $0.10
Consensus: $0.03
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about TherapeuticsMD's Q1 2024 earnings report.
TherapeuticsMD (TXMD) reported Q1 2024 earnings on May 10, 2024 before market open.
TherapeuticsMD reported revenue of $313.0K and diluted EPS of $-0.07 for Q1 2024.
Revenue missed the consensus estimate of $500.0K by $187.0K. EPS missed the consensus estimate of $0.03 by $0.10.
You can read the 10-K/A periodic report (0001213900-24-037258) directly on SEC EDGAR. The filing index links above go to sec.gov.